US CDC backs full approval of Moderna's COVID-19 vaccine
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[BENGALURU] The director of the US Centers for Disease Control and Prevention (CDC) signed off on the US Food and Drug Administration's full approval of Moderna's Covid-19 vaccine in those aged 18 and over, the agency said on Friday (Feb 4).
The vaccine has been in use under the US Food and Drug Administration's emergency use authorisation since December 2020, and is now the second fully approved vaccine for Covid-19 in the US.
Earlier on Friday, a CDC panel voted unanimously to recommend the vaccine's use, after the FDA granted full approval of the shot on Monday.
While the FDA approves vaccines, the CDC needs to sign off on how they will be implemented in the US. CDC Director Rochelle Walensky's green light is the final formality of the approval process.
The vaccine will now be sold under the brand name as Spikevax.
The Covid-19 vaccine from Pfizer and BioNTech SE received full approval for those aged 16 and over in August.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
Roughly 75 million people in the US have been fully-vaccinated with Moderna's shot. REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
